Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraham Raz

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Cancer Research|December 3, 2005
Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genesNachman Mazurek, Yun Jie Sun, Janet E Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2021
Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separationZihan Zhao, Xuejiao Xu, Hairong Cheng, et al.
Cancer Research|March 17, 2006
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancerTomoharu Fukumori, Natsuo Oka, Yukinori Takenaka, et al.
Cancer Research|September 19, 2012
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxinRussell R Braeuer, Maya Zigler, Takafumi Kamiya, et al.
Journal of Neurochemistry|March 21, 2002
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78Yongquan Luo, Jeffery M Long, Chengbiao Lu, et al.
Biochemical and Biophysical Research Communications|September 24, 2008
Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignanciesHidenori Inohara, Tatsuya Segawa, Akira Miyauchi, et al.
The American Journal of Pathology|March 25, 2004
Proteases, extracellular matrix, and cancer: a workshop of the path B study sectionYves A DeClerck, Arthur M Mercurio, M Sharon Stack, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanomaVictor G Prieto, Alexandra A Mourad-Zeidan, Vladislava Melnikova, et al.
Cancer Research|December 17, 2008
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot studyVitaly Balan, Pratima Nangia-Makker, Ann G Schwartz, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Cancer Research|December 3, 2005
Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genesNachman Mazurek, Yun Jie Sun, Janet E Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2021
Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separationZihan Zhao, Xuejiao Xu, Hairong Cheng, et al.
Cancer Research|March 17, 2006
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancerTomoharu Fukumori, Natsuo Oka, Yukinori Takenaka, et al.
Cancer Research|September 19, 2012
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxinRussell R Braeuer, Maya Zigler, Takafumi Kamiya, et al.
Journal of Neurochemistry|March 21, 2002
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78Yongquan Luo, Jeffery M Long, Chengbiao Lu, et al.
Biochemical and Biophysical Research Communications|September 24, 2008
Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignanciesHidenori Inohara, Tatsuya Segawa, Akira Miyauchi, et al.
The American Journal of Pathology|March 25, 2004
Proteases, extracellular matrix, and cancer: a workshop of the path B study sectionYves A DeClerck, Arthur M Mercurio, M Sharon Stack, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanomaVictor G Prieto, Alexandra A Mourad-Zeidan, Vladislava Melnikova, et al.
Cancer Research|December 17, 2008
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot studyVitaly Balan, Pratima Nangia-Makker, Ann G Schwartz, et al.
Pageof 13